|Hugh Jackman Has Skin Cancer For The Fifth Time—Here Are 6 Things You Need To ...|
The actor is dealing with his fifth case of basal cell carcinoma, the most common form of skin cancer. Fortunately for Jackman—and the nearly 3 million Americans diagnosed with basal cell carcinoma every year—it is also the mildest form of skin ...
SELF - Tue, 09 Feb 2016 07:45
|Hugh Jackman: What is Basal Cell Carcinoma and is it different from other ...|
The Independent - Tue, 09 Feb 2016 04:04
|Hugh Jackman Has Cancerous Growth Removed, Urges Fans To Wear Sunscreen|
Refinery29 - Mon, 08 Feb 2016 16:56
|Hugh Jackman has fifth cancerous growth removed in less than three years ...|
New York Daily News - Mon, 08 Feb 2016 12:10
|Hugh Jackman tweets selfie warning about skin cancer|
CBS News - Mon, 08 Feb 2016 09:30
|Hugh Jackman's Skin Cancer Returns — See His Frightening Pic|
Hollywood Life - Mon, 08 Feb 2016 10:38
|Hugh Jackman Posts Selfie Warning His Fans About Skin Cancer|
GoodHousekeeping.com - Tue, 09 Feb 2016 10:35
|Hugh Jackman has warned us all about Basal Cell Carcinoma – so what is it?|
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and melanoma. The first two are often bundled together as “non-melanoma skin cancer” because they pose a much smaller risk to life than melanoma. Each year, there ...
The Conversation UK - Thu, 11 Feb 2016 03:26
|Hugh Jackman Reveals Another Skin Cancer Bout|
Newsmax - Thu, 11 Feb 2016 11:18
|How To Correctly Use Sunscreen To Avoid Skin Cancer|
Tech Times - Wed, 10 Feb 2016 06:57
|'X-Men' actor Hugh Jackman takes on sunscreen campaign to social media ...|
YIBADA English - Thu, 11 Feb 2016 05:18
|Hugh Jackman is being treated for skin cancer again.|
NZCity - Mon, 08 Feb 2016 10:33
|Hugh Jackman skin cancer scare|
MyTechBits - Tue, 09 Feb 2016 10:00
|Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma|
Most people, now, who still use sunitinib at first-line therapy for patients with clear cell renal cell carcinoma (RCC), use the ultimate scheduling of two weeks on, one week off, instead of the standard four weeks on, two weeks off. And, this is the ...
OncLive - Fri, 12 Feb 2016 07:56
|Hepatocellular carcinoma A role for lncRNA in liver cancer|
New findings published in the Journal of Hepatology suggest a functional role for long non-coding RNAs (lncRNAs) in the development of hepatocellular carcinoma (HCC), which could ultimately aid prognosis and treatment of the disease. As the sixth most ...
Nature.com - Tue, 09 Feb 2016 22:00
|Exelixis' Cabozantinib Positive in Renal Cell Carcinoma Study|
Exelixis, Inc. (EXEL - Analyst Report) announced encouraging overall survival (OS) data from the phase III METEOR study on cabozantinib for the treatment of patients with advanced renal cell carcinoma (RCC). The METEOR study is evaluating a tablet ...
Zacks.com - Tue, 02 Feb 2016 13:04
|Cabozantinib significantly improved overall survival as compared with everolimus|
The Pharma Letter (registration) - Tue, 02 Feb 2016 03:40
|Renal Cell Carcinoma- Pipeline Review, Market Growth, Segment, Trends and ...|
MRS114 “Renal Cell Carcinoma Global 2015 Clinical Trials Review, H2” provides an detailed overview of Renal Cell Carcinoma scenario. Report includes top line data relating on Renal Cell Carcinoma Global clinical trials scenario. This report on Renal ...
Medgadget.com (blog) - Fri, 05 Feb 2016 21:26
|Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in ...|
Newswise — Approximately 60,000 patients in the United States will receive a diagnosis of ductal carcinoma in situ (DCIS) in 2016. DCIS is not an invasive form of cancer and the 10-year survival rate for women with DCIS is greater than 98 percent ...
Newswise (press release) - Mon, 01 Feb 2016 14:07
|Treatment Options in Renal Cell Carcinoma|
Robert A. Figlin, MD: Hello, and thank you for joining this OncLive TV Peer Exchange. There has been considerable progress in the treatment of advanced renal-cell carcinoma over the last decade, with several VEGF-targeted agents and two mTOR inhibitors ...
OncLive - Thu, 04 Feb 2016 12:26